Erivedge 150 MG capsule 28S
Ended Awarded
- Contract number
- SPE2DB25FAARP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,124
Award facts
- Contract value 100% obligated
- $18,123.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erivedge 150 mg capsules (28-count units) under a firm fixed-price contract valued at $18,123.58. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract derived from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates significant capability in delivering a broad spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The underlying IDC represents a flexible contracting mechanism enabling AmerisourceBergen to fulfill diverse pharmaceutical supply requirements for military and veteran healthcare systems globally, with the DLA planning future modernization of these pharmaceutical prime vendor contracts through the Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FAARP?
SPE2DB25FAARP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FAARP worth?
The government has obligated $18,124 on SPE2DB25FAARP.
Is contract SPE2DB25FAARP an order under another contract?
Yes. SPE2DB25FAARP is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FAARP competed?
The extent of competition for SPE2DB25FAARP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award